ICD-10-CM Billable Code

C82.1

Follicular lymphoma grade II

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma grade II is a type of blood cancer that affects the lymphatic system, which is part of the immune system. It is classified as a low- to intermediate-grade non-Hodgkin lymphoma, characterized by cancerous lymphocytes that form follicle-like structures in lymph nodes. Grade II indicates a moderate level of cell abnormality and growth rate, situated between the indolent (slow-growing) grade I and the more aggressive grade III. This diagnosis often involves the lymph nodes but can also spread to other parts of the body, including the bone marrow and spleen. Understanding this condition helps in appreciating the importance of proper diagnosis, monitoring, and treatment options.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal lymphocyte growth Age-related changes in immune system regulation Exposure to certain chemicals or radiation (though rarely) Family history of lymphomas or other blood cancers Immune system suppression or autoimmune diseases

Key Symptoms: Painless swelling or enlargement of lymph nodes, commonly in the neck, armpits, or groin Persistent fatigue or weakness Unexplained weight loss Fever without an apparent cause Night sweats Itching skin Abdominal discomfort or fullness if lymph nodes in the abdomen swell

Diagnostic & Treatment

Diagnosis Path: Diagnosis of follicular lymphoma grade II involves several medical assessments: - **Physical Exam:** Checking for swollen lymph nodes or other signs of disease. - **Biopsy:** Removal of lymph node tissue for microscopic examination to identify the characteristic follicular pattern and cell features. - **Imaging Tests:** Such as CT scans to determine the extent of disease spread. - **Laboratory Tests:** Blood tests to evaluate overall health and detect abnormal cells. - **Immunophenotyping and Molecular Studies:** To confirm the specific type of lymphoma and grade. The combination of these tests helps in accurately staging the disease and planning appropriate management.

Treatment Protocols: Treatment strategies for follicular lymphoma grade II depend on various factors, including the stage of the disease and overall health of the patient. Common approaches include: - **Observation:** Sometimes, if the disease is slow-growing and symptoms are mild, careful monitoring without immediate treatment is recommended. - **Chemotherapy:** Use of drugs to kill cancer cells. - **Immunotherapy:** Targeted therapies like monoclonal antibodies (e.g., rituximab) that help the immune system attack cancer cells. - **Radiation Therapy:** Localized treatment to shrink or eliminate affected lymph nodes. - **Targeted Therapies:** Medications that interfere with specific molecules involved in the growth of cancer cells. - **Stem Cell Transplant:** In certain cases, especially if the disease progresses, a transplant may be considered. Treatment aims to control symptoms, reduce disease burden, and improve quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.1 a billable ICD-10 code?
Yes, C82.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.1?
Clinical documentation must specify the nature of Follicular lymphoma grade II and any associated comorbidities for accurate reporting.

Cite this Clinical Reference